Capricor Therapeutics Inc (CAPR)
6.22
+0.58
(+10.28%)
USD |
NASDAQ |
May 17, 16:00
6.22
0.00 (0.00%)
After-Hours: 20:00
Capricor Therapeutics Accounts Receivable (Quarterly): 0.369M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.369M |
December 31, 2023 | 10.37M |
September 30, 2023 | 0.5476M |
June 30, 2023 | 0.5476M |
March 31, 2023 | 0.5476M |
December 31, 2022 | 0.5476M |
September 30, 2022 | 0.5476M |
June 30, 2022 | 0.5476M |
March 31, 2022 | 0.357M |
December 31, 2021 | 0.3917M |
September 30, 2021 | 0.1802M |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | 0.00 |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 |
Date | Value |
---|---|
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2020
10.37M
Maximum
Dec 2023
1.246M
Average
0.5476M
Median
Jun 2022
Accounts Receivable (Quarterly) Benchmarks
Sarepta Therapeutics Inc | 378.81M |
PTC Therapeutics Inc | 197.66M |
Solid Biosciences Inc | -- |
Cutera Inc | 37.02M |
Catalyst Pharmaceuticals Inc | 60.49M |